Cargando…

EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers

Detalles Bibliográficos
Autores principales: Bakker, Daphne S., Ariens, Lieneke F. M., Giovannone, Barbara, Hijnen, DirkJan, Delemarre, Eveline M., Knol, Edward, Nierkens, Stefan, de Bruin‐Weller, Marjolein S., Thijs, Judith L., Drylewicz, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754122/
https://www.ncbi.nlm.nih.gov/pubmed/33305359
http://dx.doi.org/10.1111/all.14492
_version_ 1783626130037669888
author Bakker, Daphne S.
Ariens, Lieneke F. M.
Giovannone, Barbara
Hijnen, DirkJan
Delemarre, Eveline M.
Knol, Edward
Nierkens, Stefan
de Bruin‐Weller, Marjolein S.
Thijs, Judith L.
Drylewicz, Julia
author_facet Bakker, Daphne S.
Ariens, Lieneke F. M.
Giovannone, Barbara
Hijnen, DirkJan
Delemarre, Eveline M.
Knol, Edward
Nierkens, Stefan
de Bruin‐Weller, Marjolein S.
Thijs, Judith L.
Drylewicz, Julia
author_sort Bakker, Daphne S.
collection PubMed
description
format Online
Article
Text
id pubmed-7754122
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77541222020-12-23 EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers Bakker, Daphne S. Ariens, Lieneke F. M. Giovannone, Barbara Hijnen, DirkJan Delemarre, Eveline M. Knol, Edward Nierkens, Stefan de Bruin‐Weller, Marjolein S. Thijs, Judith L. Drylewicz, Julia Allergy Letters to the Editor John Wiley and Sons Inc. 2020-07-24 2020-12 /pmc/articles/PMC7754122/ /pubmed/33305359 http://dx.doi.org/10.1111/all.14492 Text en © 2020 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Bakker, Daphne S.
Ariens, Lieneke F. M.
Giovannone, Barbara
Hijnen, DirkJan
Delemarre, Eveline M.
Knol, Edward
Nierkens, Stefan
de Bruin‐Weller, Marjolein S.
Thijs, Judith L.
Drylewicz, Julia
EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
title EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
title_full EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
title_fullStr EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
title_full_unstemmed EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
title_short EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
title_sort easi p‐easi: predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754122/
https://www.ncbi.nlm.nih.gov/pubmed/33305359
http://dx.doi.org/10.1111/all.14492
work_keys_str_mv AT bakkerdaphnes easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT arienslienekefm easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT giovannonebarbara easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT hijnendirkjan easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT delemarreevelinem easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT knoledward easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT nierkensstefan easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT debruinwellermarjoleins easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT thijsjudithl easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers
AT drylewiczjulia easipeasipredictingdiseaseseverityinatopicdermatitispatientstreatedwithdupilumabusingacombinationofserumbiomarkers